On Friday, Avidity Biosciences Inc (NASDAQ: RNA) opened lower -3.25% from the last session, before settling in for the closing price of $31.12. Price fluctuations for RNA have ranged from $8.86 to $56.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 148.90% over the last five years. Company’s average yearly earnings per share was noted 1.49% at the time writing. With a float of $108.55 million, this company’s outstanding shares have now reached $118.90 million.
The firm has a total of 253 workers. Let’s measure their productivity. In terms of profitability, gross margin is 80.79%, operating margin of -3209.35%, and the pretax margin is -2772.45%.
Avidity Biosciences Inc (RNA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Avidity Biosciences Inc is 9.02%, while institutional ownership is 101.10%. The most recent insider transaction that took place on Dec 18 ’24, was worth 416,154. In this transaction CSTO of this company sold 12,742 shares at a rate of $32.66, taking the stock ownership to the 72,647 shares. Before that another transaction happened on Dec 18 ’24, when Company’s Chief Financial Officer sold 11,151 for $32.66, making the entire transaction worth $364,192. This insider now owns 82,942 shares in total.
Avidity Biosciences Inc (RNA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.49% per share during the next fiscal year.
Avidity Biosciences Inc (NASDAQ: RNA) Trading Performance Indicators
Check out the current performance indicators for Avidity Biosciences Inc (RNA). In the past quarter, the stock posted a quick ratio of 17.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 343.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.90, a number that is poised to hit -0.79 in the next quarter and is forecasted to reach -3.21 in one year’s time.
Technical Analysis of Avidity Biosciences Inc (RNA)
Analysing the last 5-days average volume posted by the [Avidity Biosciences Inc, RNA], we can find that recorded value of 1.23 million was lower than the volume posted last year of 1.31 million. As of the previous 9 days, the stock’s Stochastic %D was 16.74%. Additionally, its Average True Range was 2.08.
During the past 100 days, Avidity Biosciences Inc’s (RNA) raw stochastic average was set at 0.84%, which indicates a significant decrease from 2.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.77% in the past 14 days, which was lower than the 65.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.14, while its 200-day Moving Average is $37.33. Now, the first resistance to watch is $31.34. This is followed by the second major resistance level at $32.58. The third major resistance level sits at $33.30. If the price goes on to break the first support level at $29.38, it is likely to go to the next support level at $28.66. Should the price break the second support level, the third support level stands at $27.42.
Avidity Biosciences Inc (NASDAQ: RNA) Key Stats
There are currently 119,309K shares outstanding in the company with a market cap of 3.48 billion. Presently, the company’s annual sales total 9,560 K according to its annual income of -212,220 K. Last quarter, the company’s sales amounted to 2,340 K and its income totaled -80,400 K.
